Oxidative status of platelets in normal and thalassemic blood

Thrombosis and Haemostasis

Volumn 92, Issue 5, 2004, Pages 1052-1059

  Amer, Johnny ^a   Fibach, Eitan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Flow cytometry; Free radicals; Glutathione; Platelets; Thalassemia

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; CALCIMYCIN; CALCIUM IONOPHORE; DEFEROXAMINE; GLUTATHIONE; HEMIN; HYDROGEN PEROXIDE; IRON; IRON CHELATING AGENT; OXIDIZING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; THROMBIN;

ARTICLE; BETA THALASSEMIA; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; INCUBATION TIME; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM;

ANTIOXIDANTS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL COMMUNICATION; ERYTHROCYTES; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THALASSEMIA;

EID: 9144245631     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-04-0234     Document Type: Article

References (36)

1. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
2. Eldor A. Abnormal platelet functions in beta thalassaemia. Scand J Haematol 1978; 20: 447-52.
3. Hussain MA, Hutton RA, Pavlidou O, et al. Platelet function in beta-thalassaemia major. J Clin Pathol 1979; 32: 429-33.
4. Rinder HM, Snyder EL, Bonan JL, et al. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and betathromboglobulin release. Transfusion 1993; 33: 25-29.
5. Pasin M, Yavuzer S, Tekin M, et al. Oxygen free radical-dependent increased platelet function in beta-thalassemia major patients. Thromb Res 1998; 92: 283-6.
6. Bergendi L, Benes L, Durackova Z, et al. Chemistry, physiology and pathology of free radicals. Life Sci 1999; 65: 1865-74.
7. Blockmans D, Deckmyn H, Vermylen J. Platelet activation. Blood Rev 1995; 9: 143-56.
8. Iuliano L, Colavita AR, Leo R, et al. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997; 22: 999-1006.
9. Hanson SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci U S A 1988; 85: 3184-8.
10. Eidt JF, Allison P, Noble S, et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989; 84: 18-27.
11. Kelly AB, Marzec UM, Krupski W, et al. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991; 77: 1006-12.
12. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30: 620-50.
13. Hedley DW, Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994; 15: 349-58.
14. de Zwart LL, Meerman JH, Commandeur JN, et al. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999; 26: 202-26.
15. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
16. O'Connor JE, Kimler BF, Morgan MC, et al. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry 1988; 9: 529-32.
17. Clark RA, Klebanoff SJ. Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J Immunol 1980; 124: 399-405.
18. Plummer JL, Smith BR, Sies H, et al. Chemical depletion of glutathione in vivo. Methods Enzymol 1981; 77: 50-59.
19. Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003; 70: 84-90.
20. Sanner BM, Meder U, Zidek W, et al. Effects of glucocorticoids on generation of reactive oxygen species in platelets. Steroids 2002; 67: 715-9.
21. Seno T, Inoue N, Gao D, et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001; 103: 399-409.
22. Amer J, Goldfarb A, Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry 2004; 60A(1): 73-80.
23. Bass DA, Parce JW, Dechatelet LR, et al. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983; 130: 1910-17.
24. Emmendroffer A, Hecht M, Lohmann-Matthes ML, Rocesler J. Fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 1990; 131:269-75.
25. Olas B, Wachowics B, Bald E, et al. The protective effects of resveratrol against changes in blood platelet thiols induced by platinum compounds. J. Physiol Pharmacol 2004; 55: 467-76.
26. Caccese D, Pratico D, Ghiselli A, et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation - role of arachidonic acid metabolism. Thromb Haemost 2000; 83: 485-90.
27. Levine PH, Weinger RS, Simon J, et al. Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J Clin Invest 1976; 57: 955-63.
28. Iuliano L, Violi F, Pedersen JZ, et al. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch Biochem Biophys 1992; 299: 220-4.
29. Pratico D, Iuliano L, Pulcinelli FM, et al. Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. J Lab Clin Med 1992; 119: 364-70.
30. Malle E, Ibovnik A, Stienmetz A, et al. Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a). Arterioscler Thromb 1994; 14: 345-52.
31. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2841-6.
32. Salvemini D, de Nucci G, Sneddon JM, et al. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 1989; 97: 1145-50.
33. Olas B, Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002; 106: 143-8.
34. Wilkinson IB, Megson IL, MacCallum H, et al. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 1999; 34: 690-3.
35. Labinjoh C, Newby DE, Wilkinson IB, et al. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation. Clin Sci 2001; 100: 127-35.
36. Olas B, Wachowicz B, Buczynski A. Vitamin C suppresses the cisplatin toxicity on blood platelets. Anticancer Drugs 2000; 11: 487-93.